Incorporação de medicamentos imunobiológicos para artrite reumatoide no setor suplementar de saúde do Brasil

Resumo

Rheumatoid arthritis (RA) is an autoimmune inflammatory disease of high prevalence in the general population, characterized by a progressive course and with serious and irreversible sequelae. Among the numerous drugs for the treatment, there are the disease modifying antirheumatic drugs (DMARDS), divided into synthetic and immunobiological (or biological). In recent years, there has been significant increase in the number and types of high-cost biological drugs: tumor necrosis factor inhibitors, B-lymphocyte depletor; T-cell costimulation blocker; and interleukin-6 receptor inhibitors. The objective of this work was to evaluate the panorama of the incorporation of these drugs in the Role of Procedures and Events in health of the National Agency of Supplementary Health (ANS), from the perspective of the main ones involved in the process of inclusion of these new technologies. Firstly, a literature review was carried out to construct the scenario of the Brazilian health system in which the process is inserted. The second phase includes the analysis of interviews with the representatives of the Commission for the Mobilization of Technologies in Health (CONITEC), ANS, and health operators in its various modalities, doctors and patients. The different views of the process were confronted with each other and with the information found in the bibliographic research. The perceptions of the parties involved in the analysis were quite heterogeneous, demonstrating the complexity of the process and the difficulties in meeting the diverse demands. The process of incorporating the medications showed the duplication of coverage in the public and supplementary subsector, the need for a careful and evidence-based evaluation of the new technologies for the sustainability of the health system and the importance of adherence to clinical protocols and guidelines.

Ficha do documento

Tipo

Dissertação

Ano

2019

Instituição

Fundação Getulio Vargas

Fonte

Repositório da FGV

Idioma

Português

Acesso

Acesso aberto

Identificador

oai:repositorio.fgv.br:10438/27887

Temas

TecnologiaSaúde

Palavras-chave

Arthritis, rheumatoidHealth care coordination and monitoringSupplemental healthBiological productsPrivate health care coverageHealth services coverageTechnology assessment, biomedicalArtrite reumatoideRegulação e fiscalização em saúdeSaúde suplementarProdutos biológicosCobertura de serviços privados de saúdeCobertura de serviços de saúdeAvaliação da tecnologia biomédicaAdministração de empresasServiços de saúde - BrasilSeguro-saúdeTecnologia - Avaliação